Hyderabad, April 4 Indian pharmaceutical exports reached nearly USD 29 billion by February of this financial year, registering a growth of five percent compared to the same period last year, a top official said on Saturday.
K Raja Bhanu, Director General of the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), said that the sector, currently valued at approximately USD 60 billion, is projected to grow to USD 130 billion by 2030.
"Despite global challenges, pharmaceutical exports have been one of the few sectors that has maintained its growth momentum. Pharmaceutical exports during the April-February 2025-26 period stood at USD 28.29 billion, reflecting a growth of 5.6 percent compared to the same period in 2024-25, driven by formulations, biologicals, vaccines, and Ayush products," he said.
The official further stated that exports reached USD 30.47 billion in 2024-25, reflecting a 9.4 percent year-on-year growth despite global pricing pressures and trade volatilities.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Last edited by a moderator: